AllianceBernstein’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.9M | Buy |
1,174,822
+149,200
| +15% | +$2.78M | 0.01% | 872 |
|
|
2025
Q1 | $18.6M | Sell |
1,025,622
-134,154
| -12% | -$2.43M | 0.01% | 905 |
|
|
2024
Q4 | $25.3M | Buy |
1,159,776
+136,633
| +13% | +$2.98M | 0.01% | 833 |
|
|
2024
Q3 | $28M | Buy |
1,023,143
+998,133
| +3,991% | +$27.3M | 0.01% | 787 |
|
|
2024
Q2 | $647K | Buy |
+25,010
| New | +$647K | ﹤0.01% | 2522 |
|
|
2022
Q2 | – | Sell |
-2,238
| Closed | -$104K | – | 3288 |
|
|
2022
Q1 | $104K | Hold |
2,238
| – | – | ﹤0.01% | 3099 |
|
|
2021
Q4 | $159K | Hold |
2,238
| – | – | ﹤0.01% | 3118 |
|
|
2021
Q3 | $261K | Sell |
2,238
-156
| -7% | -$18.2K | ﹤0.01% | 2991 |
|
|
2021
Q2 | $375K | Buy |
2,394
+250
| +12% | +$39.2K | ﹤0.01% | 2919 |
|
|
2021
Q1 | $406K | Sell |
2,144
-287
| -12% | -$54.3K | ﹤0.01% | 2750 |
|
|
2020
Q4 | $305K | Hold |
2,431
| – | – | ﹤0.01% | 2836 |
|
|
2020
Q3 | $265K | Hold |
2,431
| – | – | ﹤0.01% | 2858 |
|
|
2020
Q2 | $292K | Buy |
2,431
+887
| +57% | +$107K | ﹤0.01% | 2872 |
|
|
2020
Q1 | $155K | Buy |
1,544
+569
| +58% | +$57.1K | ﹤0.01% | 2849 |
|
|
2019
Q4 | $236K | Buy |
975
+37
| +4% | +$8.96K | ﹤0.01% | 2853 |
|
|
2019
Q3 | $154K | Buy |
938
+182
| +24% | +$29.9K | ﹤0.01% | 2991 |
|
|
2019
Q2 | $178K | Buy |
+756
| New | +$178K | ﹤0.01% | 2989 |
|